233 related articles for article (PubMed ID: 10488141)
1. Identification of putative sites of interaction between the human formyl peptide receptor and G protein.
Miettinen HM; Gripentrog JM; Mason MM; Jesaitis AJ
J Biol Chem; 1999 Sep; 274(39):27934-42. PubMed ID: 10488141
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution (N297A) in the conserved NPXXY sequence of the human N-formyl peptide receptor results in inhibition of desensitization and endocytosis, and a dose-dependent shift in p42/44 mitogen-activated protein kinase activation and chemotaxis.
Gripentrog JM; Jesaitis AJ; Miettinen HM
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):399-407. PubMed ID: 11085933
[TBL] [Abstract][Full Text] [Related]
3. Mutations of F110 and C126 of the formyl peptide receptor interfere with G-protein coupling and chemotaxis.
Jones BE; Miettinen HM; Jesaitis AJ; Mills JS
J Periodontol; 2003 Apr; 74(4):475-84. PubMed ID: 12747452
[TBL] [Abstract][Full Text] [Related]
4. Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence.
Bennett TA; Maestas DC; Prossnitz ER
J Biol Chem; 2000 Aug; 275(32):24590-4. PubMed ID: 10823817
[TBL] [Abstract][Full Text] [Related]
5. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
[TBL] [Abstract][Full Text] [Related]
6. Activation of mitogen-activated protein kinases by formyl peptide receptors is regulated by the cytoplasmic tail.
Rane MJ; Arthur JM; Prossnitz ER; McLeish KR
J Biol Chem; 1998 Aug; 273(33):20916-23. PubMed ID: 9694839
[TBL] [Abstract][Full Text] [Related]
7. Binding of low affinity N-formyl peptide receptors to G protein. Characterization of a novel inactive receptor intermediate.
Prossnitz ER; Schreiber RE; Bokoch GM; Ye RD
J Biol Chem; 1995 May; 270(18):10686-94. PubMed ID: 7738006
[TBL] [Abstract][Full Text] [Related]
8. High constitutive activity of the human formyl peptide receptor.
Wenzel-Seifert K; Hurt CM; Seifert R
J Biol Chem; 1998 Sep; 273(37):24181-9. PubMed ID: 9727041
[TBL] [Abstract][Full Text] [Related]
9. The role of the third intracellular loop of the neutrophil N-formyl peptide receptor in G protein coupling.
Prossnitz ER; Quehenberger O; Cochrane CG; Ye RD
Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):581-7. PubMed ID: 8373373
[TBL] [Abstract][Full Text] [Related]
10. Deficient homologous desensitization of formyl peptide receptors stably expressed in undifferentiated HL-60 cells.
Rane MJ; Prossnitz ER; Arthur JM; Ward RA; McLeish KR
Biochem Pharmacol; 2000 Jul; 60(2):179-87. PubMed ID: 10825462
[TBL] [Abstract][Full Text] [Related]
11. Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry.
Mills JS; Miettinen HM; Barnidge D; Vlases MJ; Wimer-Mackin S; Dratz EA; Sunner J; Jesaitis AJ
J Biol Chem; 1998 Apr; 273(17):10428-35. PubMed ID: 9553101
[TBL] [Abstract][Full Text] [Related]
12. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
Gripentrog JM; Miettinen HM
Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
[TBL] [Abstract][Full Text] [Related]
13. Gi-mediated translocation of GLUT4 is independent of p85/p110alpha and p110gamma phosphoinositide 3-kinases but might involve the activation of Akt kinase.
Wang L; Hayashi H; Kishi K; Huang L; Hagi A; Tamaoka K; Hawkins PT; Ebina Y
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):543-55. PubMed ID: 10642513
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu.
Mills JS; Miettinen HM; Cummings D; Jesaitis AJ
J Biol Chem; 2000 Dec; 275(50):39012-7. PubMed ID: 10960471
[TBL] [Abstract][Full Text] [Related]
15. Analysis of receptor-G protein interactions in permeabilized cells.
Wieland T; Liedel K; Kaldenberg-Stasch S; Meyer zu Heringdorf D; Schmidt M; Jakobs KH
Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):329-36. PubMed ID: 7630424
[TBL] [Abstract][Full Text] [Related]
16. Experimental evidence for lack of homodimerization of the G protein-coupled human N-formyl peptide receptor.
Gripentrog JM; Kantele KP; Jesaitis AJ; Miettinen HM
J Immunol; 2003 Sep; 171(6):3187-93. PubMed ID: 12960347
[TBL] [Abstract][Full Text] [Related]
17. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors.
Quehenberger O; Prossnitz ER; Cavanagh SL; Cochrane CG; Ye RD
J Biol Chem; 1993 Aug; 268(24):18167-75. PubMed ID: 8349692
[TBL] [Abstract][Full Text] [Related]
18. Differential roles of the NPXXY motif in formyl peptide receptor signaling.
He R; Browning DD; Ye RD
J Immunol; 2001 Mar; 166(6):4099-105. PubMed ID: 11238659
[TBL] [Abstract][Full Text] [Related]
19. Relationship of ligand-receptor dynamics to actin polymerization in RBL-2H3 cells transfected with the human formyl peptide receptor.
Hall AL; Wilson BS; Pfeiffer JR; Oliver JM; Sklar LA
J Leukoc Biol; 1997 Oct; 62(4):535-46. PubMed ID: 9335325
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of formyl peptide receptor coupling to g(i)alpha(1), g(i)alpha(2), and g(i)alpha(3).
Wenzel-Seifert K; Arthur JM; Liu HY; Seifert R
J Biol Chem; 1999 Nov; 274(47):33259-66. PubMed ID: 10559200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
